World
-
China remains one of the fastest growing pharmaceutical markets in the world
China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.
World | 27 April 2012
-
Sanofi Pasteur acquires exclusive, worldwide license for acne vaccine and treatment
Pre-clinical vaccine was developed by researchers at the University of California, San Diego.
World | 21 September 2011
-
Gilead expands access program for medications in developing world
Licenses rights to HIV pipeline products to Indian partners
World | 13 July 2011
-
Impact of counterfeit pharmaceuticals felt worldwide
The global pharmaceutical industry is plagued by the problems of counterfeit drugs, medicines and products, according to a new report on companiesandmarkets.com. The problem is not restricted to countries without comprehensive legislation or law enfo…
World | 20 June 2011
-
Biogen Idec celebrates World MS Day
Biogen Idec will join the global multiple sclerosis (MS) community in celebrating the third annual World MS Day. The company said it continues to be the industry leader in researching and providing groundbreaking therapies for MS. So far in 2011, the…
World | 25 May 2011
-
KineMed to demonstrate biomarker probes at 2011 World Pharmaceutical Congress
KineMed Inc announced that Dr Mahalakshmi Shankaran, PhD, Director of Neurobiology, will present at the 2011 World Pharmaceutical Congress on June 7th at Philadelphia, PA, USA. Dr Shankaran’s presentation, entitled “Novel Tissue and CSF Bioma…
World | 23 May 2011
-
Clinipace Worldwide acquires PFC Pharma Focus
Clinipace Worldwide has acquired all outstanding shares of privately-held PFC Pharma Focus (PFC) and its subsidiaries. Based in Zurich, Switzerland - with offices in Germany, Israel and India - PFC is a pan-European contract research provider focused…
World | 19 May 2011
-
Novartis supports influenza framework at World Health Assembly
Novartis welcomes the decision to endorse the Pandemic Influenza Preparedness Framework (PIP Framework) at the sixty-fourth World Health Assembly. The PIP Framework sets out the roles and commitments of different stakeholders, including the World Hea…
World | 19 May 2011
-
TeloVac becomes "world’s largest" pancreatic cancer vaccine trial
KAEL-GemVax announced that it had been officially notified by the independent Data Monitoring Committee that over 1000 patients have been enrolled in the TeloVac study, making it the world’s largest ever pancreatic cancer vaccine trial. This also m…
World | 06 May 2011
-
Durata Therapeutics announces worldwide rights for dalbavancin
Durata Therapeutics announced the company has attained worldwide rights for the development and commercialization of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin st…
World | 27 April 2011
